TLDR Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.
The study from November 1, 2013, involving 851 female breast cancer survivors, found that aromatase inhibitor therapy is associated with an increased risk of hair loss and thinning. Specifically, 22.4% of participants reported hair loss and 31.8% reported hair thinning. Those within 2 years of starting treatment were approximately 2.5 times more likely to experience hair loss or thinning than those never treated with aromatase inhibitors. The association persisted even after adjusting for confounders like age and chemotherapy. The study suggests that the decrease in estrogen concentrations due to aromatase inhibitor treatment may be responsible for these side effects. However, the research is limited by its cross-sectional design, reliance on self-reported data, and the single-institution setting, which may limit the generalizability of the findings. Further research is recommended to explore these associations with more detailed and objective measures.
Cited in this study
8 / 8 results
19 citations
,
June 2013 in “Annals of Oncology” Aromatase inhibitors cause male pattern hair loss in women.
17 citations
,
February 2013 in “Maturitas” The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.
46 citations
,
January 2013 in “Dermatologic Clinics” Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.
38 citations
,
December 2011 in “British Journal of Dermatology” Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.
87 citations
,
May 2011 in “Australasian Journal of Dermatology” Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.
77 citations
,
August 2009 in “British Journal of Dermatology” Aromatase gene variation may increase female hair loss risk.
159 citations
,
July 2006 in “Endocrine Reviews” Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.
139 citations
,
June 2003 in “Journal of Investigative Dermatology Symposium Proceedings” Androgenetic alopecia in women needs more research and better management strategies.